Hymovis Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Presentation/Packing

Concise Prescribing Info

Contents

HYADD 4 (Na hyaluronate hexadecylamide)

Indications/Uses

Treatment of pain in osteoarthritic joints & in the conservative treatment of the meniscal lesion of the knee & for the improvement of joint mobility through the enhancement of synovial fluid viscoelasticity.

Click to view Hymovis detailed prescribing information

Dosage/Direction for Use

IA Inj slowly in the affected joint. Treatment cycle: Osteoarthritic joints 2 inj administered at 1 wk interval. Joints w/ meniscal lesion 2 inj administered at 2 wk interval.

Click to view Hymovis detailed prescribing information

Contraindications

Hypersensitivity. Infections or skin diseases in the area of the inj site.

Click to view Hymovis detailed prescribing information

Special Precautions

Avoid treatment if the joint shows evidence of acute inflammation. Remove any joint effusion if present before inj. Intended for single use; inj in 1 joint only. Pregnancy. Childn.

Click to view Hymovis detailed prescribing information

Use In Pregnancy & Lactation

Click to view Hymovis detailed prescribing information

Adverse Reactions

Local effects eg, pain, swelling/effusion, warmth & redness. Marked inflammatory reactions.

Click to view Hymovis detailed prescribing information

Drug Interactions

Disinfectants containing quaternary ammon salts. Avoid contemporary administration w/ other IA prep.

Click to view Hymovis detailed prescribing information

Storage

View Hymovis storage conditions for details to ensure optimal shelf-life.

Description